| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 625,635 | 511,621 | 538,740 | 520,995 | | Cost of Revenue | 366,692 | 307,981 | 330,576 | 327,209 | | | Gross Profit | 258,943 | 203,640 | 208,164 | 193,786 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 222,384 | 206,620 | 212,717 | 194,843 | | Non Recurring | 2,222 | 1,998 | 2,614 | 203,428 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 34,337 | (4,978) | (7,167) | (204,485) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 52 | 145 | 143 | 250 | | Earnings Before Interest And Taxes | 34,389 | (4,833) | (7,024) | (204,282) | | Interest Expense | 5,029 | 4,914 | 5,249 | 5,304 | | Income Before Tax | 29,360 | (9,747) | (12,273) | (209,586) | | Income Tax Expense | 12,356 | (5,531) | (5,202) | (55,552) | | Minority Interest | (1,265) |
-
|
-
| 986 | | | | Net Income From Continuing Ops | 15,739 | (4,216) | (7,071) | (153,048) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,739 | (4,216) | (7,071) | (153,048) | | Preferred Stock And Other Adjustments | 561 | (561) |
-
|
-
| | | Net Income Applicable To Common Shares | $16,300 | ($4,777) | ($7,071) | ($153,048) |
|
0.11% Nasdaq 0.00%
Income Statement
